Oxygen sensing is impaired in ATM defective cells

Cell Cycle

Volumn 10, Issue 24, 2011, Pages 4311-4320

  Mongiardi, Maria Patrizia ^a   Stagni, Venturina ^b,c   Natoli, Manuela ^a   Giaccari, Danilo ^b,c   D'Agnano, Igea ^a   Falchetti, Maria Laura ^a   Barilà, Daniela ^b,c   Levi, Andrea ^a  

^a CNR   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Ataxia telangiectasia; ATM; HIF 1; Hypoxia; Oxidative stress

Indexed keywords

ATM PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; REACTIVE OXYGEN METABOLITE;

ARTICLE; ATAXIA TELANGIECTASIA; CELL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; HYDROXYLATION; HYPOXIA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE STRESS; OXYGEN SENSING; OXYGEN TENSION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION;

EID: 84055184840     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.24.18663     Document Type: Article

References (44)

1. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393-402; PMID:18498744; http:// dx.doi.org/10.1016/j.molcel.2008.04.009.
2. Dames SA, Martinez-Yamout M, De Guzman RN, Dyson HJ, Wright PE. Structural basis for Hif-1alpha/ CBP recognition in the cellular hypoxic response. Proc Natl Acad Sci USA 2002; 99:5271-6; PMID:11959977; http://dx.doi.org/10.1073/pnas.082121399.
3. Demidenko ZN, Blagosklonny MV. The purpose of the HIF-1/PHD feedback loop: to limit mTORinduced HIF-1alpha. Cell Cycle 2011; 10:1557- 62; PMID:21521942; http://dx.doi.org/10.4161/ cc.10.10.15789.
4. Nardinocchi L, Puca R, Givol D, D'Orazi G. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1alpha inhibition. Cell Cycle 2010; 9:1270-5; PMID:20234185; http://dx.doi.org/10. 4161/cc.9.7.11125.
5. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21:3995-4004; PMID:11359907; http://dx.doi. org/10.1128/MCB.21.12.3995-4004.2001.
6. Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007; 131:584-95; PMID:17981124; http://dx.doi.org/10.1016/j.cell.2007.08.045.
7. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 2007; 25:207-17; PMID:17244529; http:// dx.doi.org/10.1016/j.molcel.2007.01.001.
8. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006; 3:47; PMID:16417408; http://dx.doi.org/10.1371/journal. pmed.0030047.
9. Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007; 9:210- 7; PMID:17220880; http://dx.doi.org/10.1038/ ncb1534.
10. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9:617-28; PMID:16256737; http://dx.doi. org/10.1016/j.devcel. 2005.09.010.
11. Dang CV, Kim JW, Gao P, Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer 2008; 8:51-6; PMID:18046334; http://dx.doi. org/10.1038/nrc2274.
12. Henze AT, Acker T. Feedback regulators of hypoxiainducible factors and their role in cancer biology. Cell Cycle 2010; 9:2749-63; PMID:20603601; http:// dx.doi.org/10.4161/cc.9.14.12249.
13. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7:11-20; PMID:18177721; http://dx.doi. org/10.1016/j.cmet.2007.10.002.
14. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124:269-70; PMID:13351639.
15. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin- 1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle 2010; 9:2201-19; PMID:20519932; http://dx.doi. org/10.4161/cc.9.11. 11848.
16. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease and "Neuron- Glia Metabolic Coupling". Aging (Albany NY) 2010; 2:185-99; PMID:20442453.
17. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3:155-68; PMID:12612651; http://dx.doi.org/10.1038/ nrc1011.
18. Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759-69; PMID:18813293; http:// dx.doi.org/10.1038/nrm2514.
19. Bhatti S, Kozlov S, Farooqi AA, Naqi A, Lavin M, Khanna KK. ATM protein kinase: the linchpin of cellular defenses to stress. Cell Mol Life Sci 2011; 68:2977- 3006; PMID:21533982; http://dx.doi.org/10.1007/ s00018-011-0683-9.
20. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499- 506; PMID:12556884; http://dx.doi.org/10.1038/ nature01368.
21. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, III, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160- 6; PMID:17525332; http://dx.doi.org/10.1126/science. 1140321.
22. Watters D, Kedar P, Spring K, Bjorkman J, Chen P, Gatei M, et al. Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 1999; 274:34277- 82; PMID:10567403; http://dx.doi.org/10.1074/ jbc.274.48.34277.
23. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, et al. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 1998; 95:10146-51; PMID:9707615; http://dx.doi. org/10.1073/pnas.95.17.10146.
24. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NFkappaB activation. Mol Cell 2010; 40:63-74; PMID:20932475; http://dx.doi. org/10.1016/j.molcel.2010.09.008.
25. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2000; 2:893-8; PMID:11146653; http://dx.doi. org/10.1038/35046542.
26. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006; 4:377-89; PMID:17084711; http://dx.doi.org/10.1016/j. cmet.2006.10.002.
27. Alexander A, Walker CL. Differential localization of ATM is correlated with activation of distinct downstream signaling pathways. Cell Cycle 2010; 9:3685- 6; PMID:20890104; http://dx.doi.org/10.4161/ cc.9.18.13253.
28. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA 2010; 107:4153- 8; PMID:20160076; http://dx.doi.org/10.1073/ pnas.0913860107.
29. Guo Z, Deshpande R, Paull TT. ATM activation in the presence of oxidative stress. Cell Cycle 2010; 9:4805- 11; PMID:21150274; http://dx.doi.org/10.4161/ cc.9.24.14323.
30. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010; 330:517-21; PMID:20966255; http://dx.doi. org/10.1126/science.1192912.
31. Bencokova Z, Kaufmann MR, Pires IM, Lecane PS, Giaccia AJ, Hammond EM. ATM activation and signaling under hypoxic conditions. Mol Cell Biol 2009; 29:526-37; PMID:18981219; http://dx.doi. org/10.1128/MCB.01301-08.
32. Cam H, Easton JB, High A, Houghton PJ. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha. Mol Cell 2010; 40:509-20; PMID:21095582; http:// dx.doi.org/10.1016/j.molcel.2010. 10.030.
33. Stagni V, di Bari MG, Cursi S, Condo I, Cencioni MT, Testi R, et al. ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells. Blood 2008; 111:829-37; PMID:17932249; http:// dx.doi.org/10.1182/blood-2007-04-085399.
34. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107:43-54; PMID:11595184; http://dx.doi. org/10.1016/S0092-8674(01)00507-4.
35. Chua YL, Dufour E, Dassa EP, Rustin P, Jacobs HT, Taylor CT, et al. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J Biol Chem 2010; 285:31277-84; PMID:20675386; http://dx.doi.org/10.1074/jbc.M110.158485.
36. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol 2009; 21:894-9; PMID:19781926; http:// dx.doi.org/10.1016/j.ceb.2009.08.005.
37. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005; 1:401- 8; PMID:16054089; http://dx.doi.org/10.1016/j. cmet.2005.05.001.
38. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1:409-14; PMID:16054090; http:// dx.doi.org/10.1016/j.cmet.2005.05.002.
39. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 2007; 27:912- 25; PMID:17101781; http://dx.doi.org/10.1128/ MCB.01223-06.
40. Patten DA, Lafleur VN, Robitaille GA, Chan DA, Giaccia AJ, Richard DE. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 2010; 21:3247-57; PMID:20660157; http:// dx.doi.org/10.1091/mbc.E10-01-0025.
41. Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, et al. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 2002; 277:602-8; PMID:11679583; http://dx.doi. org/10.1074/jbc.M106798200.
42. Reichenbach J, Schubert R, Schindler D, Muller K, Bohles H, Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal 2002; 4:465-9; PMID:12215213; http://dx.doi. org/10.1089/ 15230860260196254.
43. Reliene R, Fischer E, Schiestl RH. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res 2004; 64:5148-53; PMID:15289318; http://dx.doi. org/10.1158/0008- 5472.CAN-04-0442.
44. Quintero M, Brennan PA, Thomas GJ, Moncada S. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res 2006; 66:770-4; PMID:16424008; http://dx.doi.org/10.1158/0008-5472.CAN-05-0333.